Lefitolimod Uses, Dosage, Side Effects and more
Lefitolimod is under investigation in clinical trial NCT03837756 (Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV).
| Trade Name | Lefitolimod |
| Generic | Lefitolimod |
| Lefitolimod Other Names | Lefitolimod |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
